BackgroundLeft ventricular global longitudinal strain value (GLS) can predict
functional capacity in patients with preserved left ventricular ejection
fraction (LVEF) heart failure (HF) and to assess prognosis in reduced LVEF
HF.ObjetiveCorrelate GLS with parameters of Cardiopulmonary Exercise Test (CPET) and to
assess if they could predict systolic HF patients that are more appropriated
to be referred to heart transplantation according to CPET criteria.MethodsSystolic HF patients with LVEF < 45%, NYHA functional class II and III,
underwent prospectively CPET and echocardiography with strain analysis. LVEF
and GLS were correlated with the following CPET variables:
maxVO2, VE/VCO2 slope, heart rate reduction during the
first minute of recovery (HRR) and time needed to reduce maxVO2
in 50% after physical exercise (T1/2VO2). ROC curve
analysis of GLS to predict VO2 < 14 mL/kg/min and
VE/VCO2 slope > 35 (heart transplantation’s criteria) was
performed.ResultsTwenty six patients were selected (age, 47 ± 12 years, 58% men, mean
LVEF = 28 ± 8%). LVEF correlated only with maxVO2 and
T1/2VO2. GLS correlated to all CPET variables
(maxVO2: r = 0.671, p = 0.001; VE/VCO2 slope: r =
-0.513, p = 0.007; HRR: r = 0.466, p = 0.016, and
T1/2VO2: r = -0.696, p = 0.001). GLS area under
the ROC curve to predict heart transplantation’s criteria was 0.88
(sensitivity 75%, specificity 83%) for a cut-off value of -5.7%, p =
0.03.ConclusionGLS was significantly associated with all functional CPET parameters. It
could classify HF patients according to the functional capacity and may
stratify which patients have a poor prognosis and therefore to deserve more
differentiated treatment, such as heart transplantation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.